Daniel J. Renouf

Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell– and patient-derived tumor organoids

Ling Huang, Audrey Holtzinger, Ishaan Jagan et al. · Nature Medicine · 2015 · 737 citations · Full text

Induced Pluripotent Stem Cell, Patient-derived Tumor Organoids, Engineering +12

Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Eileen M. O’Reilly, Do‐Youn Oh, Neesha C. Dhani et al. · JAMA Oncology · 2019 · 722 citations · Full text

Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution

Michelle Chan‐Seng‐Yue, Jaeseung Kim, Gavin W. Wilson et al. · Nature Genetics · 2020 · 644 citations · Full text

Systems Biology, Transcription Phenotypes, Pancreatic Cancer +7

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

Lawrence Fong, Andrew Hotson, John D. Powderly et al. · Cancer Discovery · 2019 · 321 citations · Full text

A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors

Paul C. McDonald, Stephen Chia, Philippe L. Bédard et al. · American Journal of Clinical Oncology · 2020 · 235 citations · Full text